RMTI Announces FDA Committee Review Of Triferic; HZNP Presents Results Of ACTIMMUNE(R)

Rockwell Medical, Inc. a fully integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services. Horizon Pharma plc announced the presentation of data from a Phase 2 clinical study of ACTIMMUNE